Premium
P4‐102: TWO PILOT STUDIES OF THE ALPHA‐1 ADRENORECEPTOR ANTAGONIST PRAZOSIN FOR AGITATION/AGGRESSION IN AD LEAD TO AN ALZHEIMER'S DISEASE COOPERATIVE STUDY MULTICENTER TRIAL
Author(s) -
Peskind Elaine R.,
Raskind Murray A.,
Wang Lucy
Publication year - 2014
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2014.05.1618
Subject(s) - prazosin , placebo , medicine , antagonist , randomized controlled trial , multicenter trial , anesthesia , multicenter study , receptor , alternative medicine , pathology
David B. Henley, Sherie A. Dowsett, Yun-Fei Chen, Hong Liu-Seifert, Joshua D. Grill, Rachelle Doody, Paul Aisen, Rema Raman, David S. Miller, Ann Marie Hake, Jeffrey Cummings, Eli Lilly and Company, Indianapolis, Indiana, United States; UCLA, Los Angeles, California, United States; Baylor College of Medicine, Houston, Texas, United States; UCSD, La Jolla, California, United States; UCSD, San Diego, California, United States; Bracket, Wayne, Pennsylvania, United States; Eli Lilly and Company, Indianapolis, Indiana, United States; Cleveland Clinic Lou Ruvo Center, Las Vegas, Nevada, United States. Contact e-mail: henley_david_benjamin@lilly.com